{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Schneider KM"],"funding":["European Research Council"],"pagination":["965-987"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11407779"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["80(4)"],"pubmed_abstract":["The microbiome plays a crucial role in integrating environmental influences into host physiology, potentially linking it to autoimmune liver diseases, such as autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. All autoimmune liver diseases are associated with reduced diversity of the gut microbiome and altered abundance of certain bacteria. However, the relationship between the microbiome and liver diseases is bidirectional and varies over the course of the disease. This makes it challenging to dissect whether such changes in the microbiome are initiating or driving factors in autoimmune liver diseases, secondary consequences of disease and/or pharmacological intervention, or alterations that modify the clinical course that patients experience. Potential"],"journal":["Hepatology (Baltimore, Md.)"],"pubmed_title":["Role of microbiome in autoimmune liver diseases."],"pmcid":["PMC11407779"],"funding_grant_id":["802544"],"pubmed_authors":["Kummen M","Trivedi PJ","Hov JR","Schneider KM"],"additional_accession":[]},"is_claimable":false,"name":"Role of microbiome in autoimmune liver diseases.","description":"The microbiome plays a crucial role in integrating environmental influences into host physiology, potentially linking it to autoimmune liver diseases, such as autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. All autoimmune liver diseases are associated with reduced diversity of the gut microbiome and altered abundance of certain bacteria. However, the relationship between the microbiome and liver diseases is bidirectional and varies over the course of the disease. This makes it challenging to dissect whether such changes in the microbiome are initiating or driving factors in autoimmune liver diseases, secondary consequences of disease and/or pharmacological intervention, or alterations that modify the clinical course that patients experience. Potential","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2026-06-03T21:57:56.4Z","creation":"2025-04-06T00:54:32.687Z"},"accession":"S-EPMC11407779","cross_references":{"pubmed":["37369002"],"doi":["10.1097/HEP.0000000000000506"]}}